Influvac

From Wikipedia, the free encyclopedia

Influenza (Flu)

Types
Avian A/H5N1 subtype Canine Equine Swine A/H1N1 subtype
Vaccines
2009 pandemic Pandemrix Fluzone Influvac Live attenuated Optaflu
Treatment
Amantadine Arbidol Laninamivir Oseltamivir Peramivir Rimantadine Vitamin D Zanamivir
Pandemics
2009 swine 1968–1969 Hong Kong 1957 Asian flu 1918
Outbreaks
2008 West Bengal 2007 Bernard Matthews H5N1 2007 Australian equine 2006 H5N1 India 1976 swine flu
See also
Flu season Influenza evolution Influenza research Influenza-like illness Vaccine reformulations
v t e

Influvac is a sub-unit vaccine produced and marketed by Abbott Laboratories. It contains inactivated purified surface fragments (sub-units) from the three different strains of the influenza virus (A/H1N1, A/H3N2, and Influenza B Virus) that are selected and distributed by the World Health Organization, on the basis of their latest recommendations.^[1]

The sub-unit influenza vaccine Influvac has been on the market since the early nineteen-eighties.^[1]

References

↑ 1.0 1.1 Giezeman, K.M.; J. Nauta, I.A. de Bruijn, A.M. Palache (2009). "Trivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity". Vaccine (Elsevier) 27: 2414. doi:10.1016/j.vaccine.2009.02.008. |accessdate= requires |url= (help)

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.